Regeneration of light-sensing cells in a zebrafish model of blindness.
Rod photoreceptor regeneration in a zebrafish model of Retinitis Pigmentosa.
This study is looking at how zebrafish can naturally heal their eye cells to help find new ways to restore vision for people with Retinitis Pigmentosa, a condition that causes blindness.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Sci Ctr Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11010328 on NIH RePORTER |
What this research studies
This research investigates how zebrafish can regenerate photoreceptor cells, which are crucial for vision, in the context of Retinitis Pigmentosa (RP), a condition that leads to blindness. By studying the unique regenerative abilities of zebrafish, the research aims to uncover the cellular mechanisms and genetic factors that enable these fish to replace lost retinal cells. The approach involves analyzing how specific genes and pathways interact to promote the regeneration of rod photoreceptors, which are often damaged in patients with RP. This could lead to new therapeutic strategies for restoring vision in individuals affected by this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Retinitis Pigmentosa, particularly those experiencing early stages of vision loss.
Not a fit: Patients with other forms of retinal degeneration that do not involve rod photoreceptor loss may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that restore vision for patients suffering from Retinitis Pigmentosa.
How similar studies have performed: Previous studies have shown promising results in using zebrafish models for understanding retinal regeneration, indicating potential for success in this approach.
Where this research is happening
Houston, United States
- University of Texas Hlth Sci Ctr Houston — Houston, United States (Active)
Researchers
- Principal investigator: Shihabeddin, Eyad — University of Texas Hlth Sci Ctr Houston
- Study coordinator: Shihabeddin, Eyad
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.